Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02115


Purpose:

The purpose of the study is to evaluate how the rho kinase inhibitor, fasudil, affects vascular function in patients with atherosclerosis and hyperlipidemia.


Criteria:

Inclusion Criteria: - Coronary artery disease - Hyperlipidemia -OR- - Healthy adults Exclusion Criteria: - Unstable angina, myocardial infarction or revascularization within 3 months - Symptomatic heart failure - Creatinine > 3.0 mg/dl - Liver enzymes > 3X upper limit of normal - Chronic hypoxia - Significant anemia - Chronic inflammatory disease - Pregnancy - Willing to withdraw statins for duration of study


NCT ID:

NCT00120718


Primary Contact:

Principal Investigator
Mark A Creager, MD
Brigham and Women's Hospital


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02115
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 11, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.